Differences of Prognosis and Complications between over and under 80 Years Old Ischemic Stroke Patients Who Received Intravenous Recombinant Tissue Plasminogen Activator
Proportion of elderly patients is gradually increasing in the republic of Korea. However, intravenous recombinant tissue plasminogen activator (rt-PA) therapy is recently not recommended in elderly acute ischemic stroke patients, although old age is not a proven contraindication to intravenous rt-PA. The purpose of this study was to investigate the safety and prognosis of intravenous thrombolysis in elderly patients.